Discovery of a PROTAC targeting ALK with in vivo activityGuoyi Yan, Rui Li, Meng Zhou et al.|European Journal of Medicinal Chemistry|2021Cited by 52
Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitorsGuoyi Yan, Rui Li, Chunlan Pu et al.|European Journal of Medicinal Chemistry|2019Cited by 18
Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi DesignGuoyi Yan, Rui Li, Shilong Fan et al.|Journal of Medicinal Chemistry|2021Cited by 11